StockWatch
·

KILITCH DRUGS (INDIA) LTD.

BSE: 524500

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-5.2823.8352.9482.05Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
5.9613.9121.8529.80Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue71.97+61.1%44.67+18.1%37.81+10.8%34.12-39.4%56.30+21.1%46.51+2.6%45.35
Other Income1.14-29.3%1.61-78.9%7.61+117.7%3.50+50.4%2.32-1.9%2.37-59.2%5.81
Total Income73.11+58.0%46.28+1.9%45.42+20.7%37.62-35.8%58.63+19.9%48.88-4.4%51.16
EXPENSES
Expenditure53.78+34.1%40.11+13.5%35.35+11.7%31.64-27.5%43.63+10.8%39.36-3.0%40.58
Tax5.33+316.1%1.28-5.7%1.36+14.4%1.19-67.2%3.62+37.5%2.64+51.9%1.74
PROFIT
PBT19.33+213.2%6.17-38.7%10.07+68.4%5.98-60.1%15.00+57.6%9.52-10.0%10.58
Net Profit14.00+186.2%4.89-43.9%8.72+81.8%4.79-57.9%11.37+65.2%6.88-22.2%8.85
KEY METRICS
OPM %27.05%+14.24pp12.81%+3.10pp9.71%-0.76pp10.47%-14.23pp24.70%+11.41pp13.29%+4.58pp8.71%
NPM %19.15%+8.58pp10.57%-8.62pp19.19%+6.45pp12.74%-6.66pp19.40%+5.32pp14.08%-3.21pp17.29%
EPS4.08+48.9%2.74-48.0%5.27+76.8%2.98-57.9%7.07+65.2%4.28-22.2%5.50

Corporate Events

Board MeetingKILITCH
2026
28Jul

Board Meeting

The Board of Directors considered and approved the Notice of…

BSE Filing
BonusKILITCH
2026
24Mar

1:1

BSE Filing
Board MeetingKILITCH
2026
13Mar

Board Meeting

The EGM will consider increasing the authorized share capita…

BSE Filing
Board MeetingKILITCH
2025
12Jul

Board Meeting

Approve issue period and letter of offer

BSE Filing
Board MeetingKILITCH
2024
12Nov

Board Meeting

Consider and approve unaudited Financial Results (Standalone…

BSE Filing
Board MeetingKILITCH
2024
8Feb

Board Meeting

Consider and approve the unaudited standalone and consolidat…

BSE Filing
Board MeetingKILITCH
2023
9Nov

Board Meeting

Consider and approve the unaudited Financial Results (Standa…

BSE Filing
Board MeetingKILITCH
2023
11Aug

Board Meeting

consider and approve the unaudited Financial Results (Standa…

BSE Filing